Market Tracker

05/27 5:16pm ET

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

51.66
Delayed Data
As of May 27
 +0.07 / +0.14%
Today’s Change
49.51
Today|||52-Week Range
72.31
-21.30%
Year-to-Date
8 Top Stocks Billionaires Love
7:38am / MotleyFool.com - Paid Partner Content
Billionaires are Dumping These 3 Stocks
May 25 / MotleyFool.com - Paid Partner Content
Endo Could Be the Next Activist Target in Generics
May 28 / TheStreet.com - Paid Partner Content
Is This the Perfect Time to Buy Teva?
May 24 / TheStreet.com - Paid Partner Content
Stocks Near 5-Week Lows
May 26 / GuruFocus News - Paid Partner Content
Allergan to do Smaller Deals and Boost Credit Rating
May 23 / TheStreet.com - Paid Partner Content
5 Health Care Stocks Whose Charts Tell You to Wait to Buy
May 26 / TheStreet.com - Paid Partner Content
AstraZeneca's Severe Asthma Drug Positive in Phase III
May 18 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close51.59
Today’s open51.82
Day’s range51.56 - 52.45
Volume3,708,955
Average volume (3 months)6,183,698
Market cap$52.8B
Dividend yield2.63%
Data as of 4:02pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-48.62%
Earnings growth (this year)-3.08%
Earnings growth (next 5 years)+7.20%
Revenue growth (last year)-3.25%
P/E ratio26.8
Price/Sales2.89
Price/Book1.77

Competitors

 Today’s
change
Today’s
% change
DEPODepomed Inc+0.33+1.65%
BGNEBeiGene Ltd-0.32-1.16%
DNAIProNAi Therapeutics ...-0.58-9.06%
OASMOasmia Pharmaceutica...-0.03-0.64%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$1.18
Annual revenue (last year)$19.6B
Annual profit (last year)$1.6B
Net profit margin8.09%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Erez Vigodman
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Tel Aviv

Forecasts